Literature DB >> 30961830

The Opposing Roles of PIK3R1/p85α and PIK3R2/p85β in Cancer.

Jesús Vallejo-Díaz1, Monica Chagoyen2, Manuel Olazabal-Morán1, Ana González-García1, Ana Clara Carrera3.   

Abstract

Dysregulation of the PI3K/PTEN pathway is a frequent event in cancer, and PIK3CA and PTEN are the most commonly mutated genes after TP53. PIK3R1 is the predominant regulatory isoform of PI3K. PIK3R2 is an ubiquitous isoform that has been so far overlooked, but data from The Cancer Genome Atlas shows that increased expression of PIK3R2 is also frequent in cancer. In contrast to PIK3R1, which is a tumor-suppressor gene, PIK3R2 is an oncogene. We review here the opposing roles of PIK3R1 and PIK3R2 in cancer, the regulatory mechanisms that control PIK3R2 expression, and emerging therapeutic approaches targeting PIK3R2.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  LUSC; PIK3R2; mRNA overexpression; p85β; tumor driver

Mesh:

Substances:

Year:  2019        PMID: 30961830     DOI: 10.1016/j.trecan.2019.02.009

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  34 in total

1.  Taohong Siwu Decoction exerts anticancer effects on breast cancer via regulating MYC, BIRC5, EGF and PIK3R1 revealed by HTS2 technology.

Authors:  Yu Gui; Yifei Dai; Yumei Wang; Shengrong Li; Lei Xiang; Yuqin Tang; Xue Tan; Tianli Pei; Xilinqiqige Bao; Dong Wang
Journal:  Comput Struct Biotechnol J       Date:  2022-06-26       Impact factor: 6.155

2.  Precision Targeting of Mutant PI3Kα in Cancer by Selective Degradation.

Authors:  Bart Vanhaesebroeck; John E Burke; Ralitsa R Madsen
Journal:  Cancer Discov       Date:  2022-01       Impact factor: 38.272

3.  FER-mediated phosphorylation and PIK3R2 recruitment on IRS4 promotes AKT activation and tumorigenesis in ovarian cancer cells.

Authors:  Yanchun Zhang; Xuexue Xiong; Qi Zhu; Jiali Zhang; Shengmiao Chen; Yuetong Wang; Jian Cao; Li Chen; Linjun Hou; Xi Zhao; Piliang Hao; Jian Chen; Min Zhuang; Dake Li; Gaofeng Fan
Journal:  Elife       Date:  2022-05-12       Impact factor: 8.713

4.  The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma.

Authors:  Yongying Zhou; Xiao Wang; Weibing Zhang; Huiyong Liu; Daoquan Liu; Ping Chen; Deqiang Xu; Jianmin Liu; Yan Li; Guang Zeng; Mingzhou Li; Zhonghua Wu; Yingao Zhang; Xinghuan Wang; Michael E DiSanto; Xinhua Zhang
Journal:  Front Oncol       Date:  2021-04-23       Impact factor: 6.244

Review 5.  The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling.

Authors:  Boris Y Shorning; Manisha S Dass; Matthew J Smalley; Helen B Pearson
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

6.  A PIK3R2 Mutation in Familial Temporal Lobe Epilepsy as a Possible Pathogenic Variant.

Authors:  Yishu Wang; Jing Peng; Shuwei Bai; Haojun Yu; Hong He; Chunxiang Fan; Yong Hao; Yangtai Guan
Journal:  Front Genet       Date:  2021-05-10       Impact factor: 4.599

7.  Exploring the Mechanism of Scutellaria baicalensis Georgi Efficacy against Oral Squamous Cell Carcinoma Based on Network Pharmacology and Molecular Docking Analysis.

Authors:  Fanfan Hou; Yang Liu; YaHsin Cheng; Ni Zhang; Wenpeng Yan; Fang Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-13       Impact factor: 2.629

Review 8.  Class IA PI3K regulatory subunits: p110-independent roles and structures.

Authors:  Millie Fox; Helen R Mott; Darerca Owen
Journal:  Biochem Soc Trans       Date:  2020-08-28       Impact factor: 5.407

9.  A comparison of machine learning classifiers for dementia with Lewy bodies using miRNA expression data.

Authors:  Daichi Shigemizu; Shintaro Akiyama; Yuya Asanomi; Keith A Boroevich; Alok Sharma; Tatsuhiko Tsunoda; Takashi Sakurai; Kouichi Ozaki; Takahiro Ochiya; Shumpei Niida
Journal:  BMC Med Genomics       Date:  2019-10-30       Impact factor: 3.063

10.  Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces.

Authors:  Sabina Sangaletti; Fabio Iannelli; Federica Zanardi; Valeria Cancila; Paola Portararo; Laura Botti; Davide Vacca; Claudia Chiodoni; Arianna Di Napoli; Cesare Valenti; Celeste Rizzello; Maria Carmela Vegliante; Federica Pisati; Alessandro Gulino; Maurilio Ponzoni; Mario Paolo Colombo; Claudio Tripodo
Journal:  EBioMedicine       Date:  2020-10-20       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.